Arcus Biosciences (RCUS) Insider Trading & Ownership → The #1 Biotech Stock to Have on Your Radar in 2024… (From Huge Alerts) (Ad) Free rcus Stock Alerts $15.43 -0.07 (-0.45%) (As of 04/24/2024 ET) Add Compare Share Share Insider TradesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Arcus Biosciences (NYSE:RCUS) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage13.80%Number OfInsiders Buying(Last 12 Months)2Amount OfInsider Buying(Last 12 Months)$339.45 MNumber OfInsiders Selling(Last 12 Months)4Amount OfInsider Selling(Last 12 Months)$3.42 M Get RCUS Insider Trade Alerts Want to know when executives and insiders are buying or selling Arcus Biosciences stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address RCUS Insider Buying and Selling by Quarter Ad Huge AlertsThe #1 Biotech Stock to Have on Your Radar in 2024… Revenues exploding, a $18.70 price target, and highly lucrative addressable markets make this one you cannot ignore!Learn more about why Zack’s has a BULLISH nearly $19 price target on BSEM right now! Arcus Biosciences Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails3/27/2024Jennifer JarrettCOOSell11,551$17.55$202,720.05 3/18/2024Jennifer JarrettCOOSell13,449$17.92$241,006.08 2/26/2024Jennifer JarrettCOOSell24,555$20.07$492,818.85 2/26/2024Juan C JaenPresidentSell3,900$20.06$78,234.00 1/29/2024Gilead Sciences, Inc.Major ShareholderBuy15,238,095$21.00$319,999,995.00 1/2/2024Juan C JaenPresidentSell6,975$20.09$140,127.75 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 1/2/2024Robert C Goeltz IICFOSell2,004$20.00$40,080.00 12/22/2023Jennifer JarrettCOOSell21,521$17.76$382,212.96 9/22/2023Jennifer JarrettCOOSell21,369$19.99$427,166.31 7/28/2023Jennifer JarrettCOOSell45,000$20.25$911,250.00 7/3/2023Alexander AzoyCAOSell1,018$20.41$20,777.38 6/28/2023Gilead Sciences, Inc.Major ShareholderBuy1,010,000$19.26$19,452,600.00 6/22/2023Jennifer JarrettCOOSell12,437$19.12$237,795.44 6/16/2023Jennifer JarrettCOOSell12,563$19.35$243,094.05 (Data available from 1/1/2013 forward) RCUS Insider Trading Activity - Frequently Asked Questions Who is on Arcus Biosciences's Insider Roster? The list of insiders at Arcus Biosciences includes Alexander Azoy, Carolyn C Tang, Gilead Sciences, Inc., Jennifer Jarrett, Juan C Jaen, Robert C Goeltz II, and Terry J Rosen. Learn more on insiders at RCUS. What percentage of Arcus Biosciences stock is owned by insiders? 13.80% of Arcus Biosciences stock is owned by insiders. Learn more on RCUS's insider holdings. Which Arcus Biosciences insiders have been buying company stock? The following insider purchased RCUS shares in the last 24 months: Gilead Sciences, Inc. ($339,452,595.00). How much insider buying is happening at Arcus Biosciences? Insiders have purchased a total of 16,248,095 RCUS shares in the last 24 months for a total of $339,452,595.00 bought. Which Arcus Biosciences insiders have been selling company stock? The following insiders have sold RCUS shares in the last 24 months: Alexander Azoy ($20,777.38), Carolyn C Tang ($106,590.25), Jennifer Jarrett ($4,257,837.61), Juan C Jaen ($403,108.51), Robert C Goeltz II ($115,509.75), and Terry J Rosen ($488,945.77). How much insider selling is happening at Arcus Biosciences? Insiders have sold a total of 251,040 Arcus Biosciences shares in the last 24 months for a total of $5,392,769.27 sold. More Insider Trading Tools from MarketBeat Related Companies: Zai Lab Insider Buying Kura Oncology Insider Buying Ligand Pharmaceuticals Insider Buying Morphic Insider Buying ANI Pharmaceuticals Insider Buying Dynavax Technologies Insider Buying Protagonist Therapeutics Insider Buying Edgewise Therapeutics Insider Buying Ardelyx Insider Buying Verona Pharma Insider Buying Insider Tracking Tools: CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country: U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles: Pagaya Technologies: An AI Fintech That Insiders Are BuyingThe 5 Stocks Most Sold By Insiders This Year3 Cheap Stocks Insiders are Buying: Investors Should Avoid 1The 5 Hottest CEO Stock Purchases So Far This Year3 Cheap Stocks that Insiders Bought in Q1 This page (NYSE:RCUS) was last updated on 4/24/2024 by MarketBeat.com Staff From Our PartnersThe #1 Biotech Stock to Have on Your Radar in 2024… Huge AlertsHe Is Giving Away BitcoinCrypto Swap ProfitsBitcoin Rockets To Record High But Buy THIS InsteadParadigm Presstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersFed launches fourth dollar overhaulStansberry ResearchThe #1 Crypto for 2024InvestorPlaceDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill Publishing Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Arcus Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
